BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1618904)

  • 1. Chondrodysplasia in transgenic mice harboring a 15-amino acid deletion in the triple helical domain of pro alpha 1(II) collagen chain.
    Metsäranta M; Garofalo S; Decker G; Rintala M; de Crombrugghe B; Vuorio E
    J Cell Biol; 1992 Jul; 118(1):203-12. PubMed ID: 1618904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced amounts of cartilage collagen fibrils and growth plate anomalies in transgenic mice harboring a glycine-to-cysteine mutation in the mouse type II procollagen alpha 1-chain gene.
    Garofalo S; Vuorio E; Metsaranta M; Rosati R; Toman D; Vaughan J; Lozano G; Mayne R; Ellard J; Horton W
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9648-52. PubMed ID: 1946380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of mutations of cartilage matrix genes on matrix structure, gene activity and chondrogenesis.
    So CL; Kaluarachchi K; Tam PP; Cheah KS
    Osteoarthritis Cartilage; 2001; 9 Suppl A():S160-73. PubMed ID: 11680681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of cartilage collagen fibrils in mice carrying a dominant negative Col2a1 transgene affects chondrocyte differentiation.
    Barbieri O; Astigiano S; Morini M; Tavella S; Schito A; Corsi A; Di Martino D; Bianco P; Cancedda R; Garofalo S
    Am J Physiol Cell Physiol; 2003 Dec; 285(6):C1504-12. PubMed ID: 12917109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted disruption of Col11a2 produces a mild cartilage phenotype in transgenic mice: comparison with the human disorder otospondylomegaepiphyseal dysplasia (OSMED).
    Li SW; Takanosu M; Arita M; Bao Y; Ren ZX; Maier A; Prockop DJ; Mayne R
    Dev Dyn; 2001 Oct; 222(2):141-52. PubMed ID: 11668593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal craniofacial morphology and cartilage structure in transgenic mice harboring a Gly --> Cys mutation in the cartilage-specific type II collagen gene.
    Rintala M; Metsäranta M; Garofalo S; de Crombrugghe B; Vuorio E; Rönning O
    J Craniofac Genet Dev Biol; 1993; 13(3):137-46. PubMed ID: 8227287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal abnormalities and ultrastructural changes of cartilage in transgenic mice expressing a collagen II gene (COL2A1) with a Cys for Arg-alpha1-519 substitution.
    Arita M; Li SW; Kopen G; Adachi E; Jimenez SA; Fertala A
    Osteoarthritis Cartilage; 2002 Oct; 10(10):808-15. PubMed ID: 12359167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retarded skeletal development in transgenic mice with a type II collagen mutation.
    Savontaus M; Metsranta M; Vuorio E
    Am J Pathol; 1996 Dec; 149(6):2169-82. PubMed ID: 8952549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spondylometaphyseal dysplasia in mice carrying a dominant negative mutation in a matrix protein specific for cartilage-to-bone transition.
    Jacenko O; LuValle PA; Olsen BR
    Nature; 1993 Sep; 365(6441):56-61. PubMed ID: 8361538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ hybridization studies on the expression of type X collagen in fetal human cartilage.
    Reichenberger E; Aigner T; von der Mark K; Stöss H; Bertling W
    Dev Biol; 1991 Dec; 148(2):562-72. PubMed ID: 1743401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perlecan is essential for cartilage and cephalic development.
    Arikawa-Hirasawa E; Watanabe H; Takami H; Hassell JR; Yamada Y
    Nat Genet; 1999 Nov; 23(3):354-8. PubMed ID: 10545953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Y-position collagen II mutation disrupts cartilage formation and skeletal development in a transgenic mouse model of spondyloepiphyseal dysplasia.
    Gaiser KG; Maddox BK; Bann JG; Boswell BA; Keene DR; Garofalo S; Horton WA
    J Bone Miner Res; 2002 Jan; 17(1):39-47. PubMed ID: 11771668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of type I, type II, and type X collagen genes during altered endochondral ossification in the femoral epiphysis of osteosclerotic (oc/oc) mice.
    Yamasaki A; Itabashi M; Sakai Y; Ito H; Ishiwari Y; Nagatsuka H; Nagai N
    Calcif Tissue Int; 2001 Jan; 68(1):53-60. PubMed ID: 12037624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An inbred line of transgenic mice expressing an internally deleted gene for type II procollagen (COL2A1). Young mice have a variable phenotype of a chondrodysplasia and older mice have osteoarthritic changes in joints.
    Helminen HJ; Kiraly K; Pelttari A; Tammi MI; Vandenberg P; Pereira R; Dhulipala R; Khillan JS; Ala-Kokko L; Hume EL
    J Clin Invest; 1993 Aug; 92(2):582-95. PubMed ID: 8349798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice lacking matrilin-1 (cartilage matrix protein) have alterations in type II collagen fibrillogenesis and fibril organization.
    Huang X; Birk DE; Goetinck PF
    Dev Dyn; 1999 Dec; 216(4-5):434-41. PubMed ID: 10633862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis.
    Li Y; Lacerda DA; Warman ML; Beier DR; Yoshioka H; Ninomiya Y; Oxford JT; Morris NP; Andrikopoulos K; Ramirez F
    Cell; 1995 Feb; 80(3):423-30. PubMed ID: 7859283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracheomalacia in a neonate with kniest dysplasia: histopathologic and ultrastructural features.
    Hicks J; De Jong A; Barrish J; Zhu SH; Popek E
    Ultrastruct Pathol; 2001; 25(1):79-83. PubMed ID: 11297324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dominant interference collagen X mutation disrupts hypertrophic chondrocyte pericellular matrix and glycosaminoglycan and proteoglycan distribution in transgenic mice.
    Jacenko O; Chan D; Franklin A; Ito S; Underhill CB; Bateman JF; Campbell MR
    Am J Pathol; 2001 Dec; 159(6):2257-69. PubMed ID: 11733375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type II collagen pro-alpha-chains containing a Gly574Ser mutation are not incorporated into the cartilage matrix of transgenic mice.
    Maddox BK; Garofalo S; Keene DR; Smith C; Horton WA
    Matrix Biol; 1997 Aug; 16(3):93-103. PubMed ID: 9314159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retarded chondrogenesis in transgenic mice with a type II collagen defect results in fracture healing abnormalities.
    Hiltunen A; Metsäranta M; Virolainen P; Aro HT; Vuorio E
    Dev Dyn; 1994 Aug; 200(4):340-9. PubMed ID: 7994081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.